Analysis of Val158Met genotype polymorphisms in the COMT locus and correlation with IL-6 and IL-10 expression in fibromyalgia syndrome

Journal of Clinical Research

Volumn 9, Issue 1-10, 2006, Pages 1-10

  Garcia Fructuoso, Ferran J ^a   Beyer, Katrin ^b   Lao Villadóniga, Jose I ^c  

^a Centro Internacional de Medicina Avanzada   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Laboratorio de Analisis Dr Echevarne   (Spain)

Author keywords

COMT polymorphism; Fibromyalgia; IL 10; IL 6; Met allele

Indexed keywords

CATECHOL METHYLTRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 6; METHIONINE; VALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FIBROMYALGIA; GENOTYPE; HUMAN; MALE; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

EID: 33646021279     PISSN: 13695207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 1990; 33: 160-172.
2. Wolfe F, Ross K, Anderson J et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism 1995; 38: 19-28.
3. Carmona L, Ballina J, Gabriel R et al; EPISER Study Group. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Annals of the Rheumatic Diseases 2001; 60: 1040-1045.
4. Buskila D, Neumann L. Genetics of fibromyalgia. Current Pain and Headache Reports 2005; 9: 313-315.
5. Zubieta JK, Heitzeg MM, Smith YR et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003; 299: 1240-1243
6. Martinez-Lavin M. Fibromyalgia as a sympathetically maintained pain syndrome. Current Pain and Headache Reports 2004; 8: 385-389.
7. Rowbotham MC. Is fibromyalgia a neuropathic pain syndrome? Journal of Rheumatology 2005; Suppl. 75: 38-40.
8. Le Marchand L, Donlon T, Kolonel LN et al. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiology, Biomarkers & Prevention 2005; 14: 1998-2003.
9. Contin M, Martinelli P, Mochi M et al. Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. Movement Disorders 2005; 20: 734-739.
10. Emin Erdal M, Herken H, Yilmaz M et al. Significance of the catechol-O-methyltransferase gene polymorphism in migraine. Brain Research. Molecular Brain Research 2001; 94: 193-196.
11. Berthele A, Platzer S, Jochim B et al. COMT Val(108/158)Met genotype affects the mu-opioid receptor system in the human brain: evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression. Neuroimage 2005; 28: 185-193.
12. Oka T, Auo S, Hori T. Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Research 1994; 656: 236-244.
13. Watkins LR, Wiertelak EP, Goehler LE et al. Characterization of cytokine-induced hyperalgesia. Brain Research 1994; 654: 15-26.
14. Oka T, Oka K, Hosoi M et al. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Research 1995; 692: 123-128.
15. Deleo JA, Colburn RW, Nichols M et al. Interleukin-6 mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. Journal of Interferon and Cytokine Research 1996; 16: 695-700.
16. Wallace DJ, Bowman R, Wormsley S et al. Cytokines and immune regulation in the primary fibromyalgia (fibrositis) syndrome. Arthritis and Rheumatism 1989; 32: 1334-1335.
17. Hader N, Rimon D, Kinarty A et al. Altered interleukin-2 secretion in patients with fibromyalgia syndrome. Arthritis and Rheumatism 1991; 34: 866-872.
18. Maes M, Libbrecht I, van Hunsel F et al. The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotropic cytokines. Psychoneuroendocrinology 1999; 24: 371-383.
19. Elenkov IJ, Iezzoni DG, Daly A et al. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005; 12: 255-269.
20. Moore KW, Ho ASY, Xu-Amano J. Molecular biology of interleukin-10 and its receptor. In: DeVries JE, de Waal Malefyt R, Editors. Interleukin-10. Austin, TX: R.G. Landes Company, 1995: 1-9.
21. Milligan ED, Sloane EM, Langer SJ et al. Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Molecular Pain 2005; 1: 9.
22. Torpy DJ, Papanicolaou DA, Lotsikas AJ et al. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis and Rheumatism 2000; 43: 872-880.
23. Takeda K, Sawamura S, Tamai H et al. Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation. Anesthesiology 2005; 103: 837-844.
24. Preece P, Virley DJ, Costandi M et al. An optimistic view for quantifying mRNA in postmortem human brain. Brain Research. Molecular Brain Research 2003; 116: 7-16.
25. Beyer K, Lao JI, Carrato C et al. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies. Neuropathology and Applied Neurobiology 2004; 30: 601-607.
26. Gursoy S, Erdal E, Herken H et al. Significance of catechol-O- methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatology International 2003; 23: 104-107.
27. Steinsson K, Alarcon-Riquelme ME. Genetic aspects of rheumatic diseases. Scandinavian Journal of Rheumatology 2005; 34: 167-177.
28. Kiecolt-Glaser JK, McGuire L, Robles TF et al. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology 2002; 53: 83-107.
29. Lio D, Candore G, Crivello A et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful aging: genetic background of male centenarians is protective against coronary heart disease. Journal of Medical Genetics 2004; 41: 790-794.